GLOBALT Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Sell
52,696
-914
-2% -$213K 0.45% 29
2026
Q1
$13.1M Sell
53,610
-1,176
-2% -$274K 0.47% 30
2025
Q4
$11.3M Sell
54,786
-776
-1% -$153K 0.41% 32
2025
Q3
$10.3M Buy
55,562
+39,297
+242% +$6.73M 0.38% 35
2025
Q2
$2.48M Sell
16,265
-1,116
-6% -$172K 0.1% 109
2025
Q1
$2.88M Sell
17,381
-785
-4% -$123K 0.12% 102
2024
Q4
$2.63M Sell
18,166
-268
-1% -$41.5K 0.1% 107
2024
Q3
$2.99M Sell
18,434
-732
-4% -$117K 0.11% 102
2024
Q2
$2.8M Sell
19,166
-217
-1% -$32.3K 0.11% 103
2024
Q1
$3.07M Sell
19,383
-848
-4% -$135K 0.12% 94
2023
Q4
$3.17M Buy
+20,231
New +$3.1M 0.13% 94

Other funds holding JNJ

GLOBALT Investments's JNJ Position: Q2 2026 in Review

GLOBALT Investments reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $213K and leaving 52,696 shares worth $13.4M. The position accounts for 0.45% of the portfolio, ranked #29.

GLOBALT Investments first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • GLOBALT Investments held 52,696 shares of Johnson & Johnson worth $13.4M as of Q2 2026.
  • GLOBALT Investments sold 914 Johnson & Johnson shares in Q2 2026, an estimated $213K.
  • Johnson & Johnson made up 0.45% of GLOBALT Investments's portfolio in Q2 2026, its #29 holding.
  • GLOBALT Investments first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.